Link: https://links.sgx.com/1.0.0/corporate-announcements/CJPDSMLQKLO569Z2/9a672884685a9bb94e920afd06c0ab7b9d1fed07d0623508a2bea3541b7a3beb

Summary: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced a proposed disposal of its remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. and Haleon CH SARL for a total consideration of RMB 1,623,466,666.67. This transaction is expected to result in a gain on disposal of approximately RMB 1.54 billion for the company. The completion of the disposal is contingent upon shareholders' approval and the fulfillment of regulatory requirements, after which Tianjin Pharmaceutical will no longer hold any stake in Tianjin TSKF Pharmaceutical.